About private equity
How private equity invests in privately-owned businesses, supports jobs and creates prosperity.
About us
We represent Europe’s private equity, venture capital and infrastructure industry.
Section Highlights
Industry standards
Invest Europe is the guardian of the industry’s professional standards.
Section Highlights
Policy
Working with policymakers to develop legislation that helps drive growth and prosperity.
Section Highlights
Research
The authoritative data source on European private equity activity.
Section Highlights
Events & training
A comprehensive suite of conferences, networking events and training courses.
Section Highlights
News & opinion
Up-to-the-minute policy and industry news, insights and opinions.
Section Highlights
Members
Login to access your exclusive member-only content and account information.
Login
Not a member? Join us
- Operate to the highest level of professional standards
- Access authoritative industry research and data
- Navigate the complex EU regulatory environment
- Network and engage with industry leaders
Venture Capital Forum 2021
12 - 13 Oct 2021
Paris
Agenda
While the 2021 agenda is still under development, we invite you to consult the 2020 agenda below.
11:00 – 11:15
Welcome
Eric de Montgolfier CEO, Invest Europe
11:15 – 12:30
Current dynamics in European Venture Capital and their impact on fund strategies
Presentation of the latest data from the EIF from the past 6 months with a look at deal dynamics, the evolution of funding round sizes and price levels. What are the implications for VCs in terms of portfolio management and selection of investment strategy? What changes are needed and which innovations do VCs need to adopt to thrive?
Uli Grabenwarter Deputy Director – Equity Investments, EIF
Dina Chaya Partner, Neomed Management
Staffan Helgesson General Partner, Creandum
Nenad Marovac Founder, Managing Partner, DN Capital
Katya Smirnyagina Executive Director Capricorn Health-tech Fund, Capricorn Partners
12:30 – 13:45
Networking Break
13:45 – 14:25
Upgrading Competitiveness for Recovery : The imperatives for a new economic and business model.
A new world of competitiveness is emerging from the crisis. It creates vast opportunities for the daring. How will the economic and business environment influence the strategies of companies and governments? What do companies need to do to thrive? As closing keynote speech, Professor Stephane Garelli, Professor Emeritus at IMD and Founder of the IMD World Competitiveness Center, will look at the changes and challenges of the future and how leaders and companies can react to remain competitive.
Professor Stéphane Garelli Professor Emeritus of World Competitiveness, IMD business school and at the University of Lausanne, Switzerland
15:00 – 15:30
Fireside Chat with Founders: Themis Bioscience
Themis Bioscience is a vaccine development company based in Vienna, Austria. Since the outbreak of the Covid-19 pandemic, the company has leveraged their vaccine platform technology to prioritize their work on the development of a vaccine against SARS-CoV-2, the virus strain that causes Covid-19. In this fireside chat, CEO and Founder, Eric Tauber, will discuss the company’s journey from VC-backed start-up to its acquisition by Merck in May 2020, as well as their on-going work in the fight against Covid-19.
Erich Tauber CEO & Founder, Themis Bioscience
Christina Pamberg Managing Partner, Alcyon Holding
15:30 – 16:00
Fireside Chat with Founders: Mirakl
Mirakl is the only marketplace SaaS platform that empowers both B2B and B2C organizations to launch and grow an enterprise marketplace at scale. On September 22nd the company announced that it has raised US$300 million at a valuation of over US$1.5 billion led by Permira and with participation from the company’s long term VC investors. In this session, Alexandre Margoline of Permira will chat with CEO Adrien Nussebaum, discussing the Mirakl development to date and the role venture capital support has played, the impact of Covid and the company’s response and the next steps as the company enters a new period of hypergrowth.
Adrien Nussebaum CEO, Mirakl
Alexandre Margoline Partner, Head of Paris, Permira
16:15 – 17:15
LP Panel: Making allocation decisions & the factors that differentiate VCs
What is the decision-making process for allocations? What are the unique selling points that differentiate VCs and convince LPs to change allocations?
Marcus Peter Partner, GSK Stockmann
Fidel Manolopoulos Principal, Hermes GPE
Miriam Schmitter Managing Director, Commonfund Capital
Joe Schorge Managing Partner, Isomer Capital
Stephen Lowery Managing Director, Silicon Valley Bank
Invest Europe - Events & training calendar
A comprehensive suite of conferences, networking events and training courses.